IPIC Message Board - Msg: 3225851

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IPIC

IPIC 0.0001000

0.0%

Aug 15 3:35 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: NeuroInvestment who wrote (986)	1/21/1998 10:13:00 PM
From: Scott Pratho	of 1359

I just found a very nice on-line obesity newsletter: obesity-news.com It's worth a look. One of the quotes: "New data has surfaced recently indicating that fenfluramine and heart valve damage is not nearly as common as reported by the Food and Drug Administration (FDA). Tests by doctors on 750 patients at 21 medical sites across the US, suggest that the rate of heart valve disease in patients taking phen/fen is substantially less than the 30 percent found in the FDA study. Dr. Daniel Kulick of Mission Internal Medical Group, Mission Viejo, CA said, "I think this is a real issue, but I strongly doubt the incidence [of heart valve disease] is anywhere near as high as a third". Dr. Kulick performed echocardiograms on 50 of his patients, but only one satisfies the FDA criteria for heart-valve leakage." I agree, all we have to do is refer to the decade of European experience with their 11 million patients. BTW, Neuroinvestment: I am enjoying your website.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next